[Clinical study on treatment of arteriosclerosis obliterans using huangqi tongmai decoction]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Jul;17(7):408-9.
[Article in Chinese]

Abstract

Objective: To test and verify the effects of Huangqi Tongmai Decoction (HQTMI) regulating blood lipid in treating arteriosclerosis obliterans (ASO).

Methods: Thirty-two cases of ASO was treated with HQTMD for two months. The drug was in water decoction, oral taken.

Results: Compared with the blood lipid level before treatment, the high density lipoprotein of cholesterol (HDL-C) was increased, the low density lipoprotein of cholesterol (LDL-C), atherogenic index (AI) was decreased (P < 0.01). The serum total cholesterol (TC), triglyceride (TG), very low density lipoprotein of cholesterol (VLDL), apolipoprotein A1 (apoA1), apolipoprotein B100 (apoB100) were all changed (P < 0.05). apoA1/apoB100 ratio increased.

Conclusion: HQTMD could regulate blood lipid. This method was effective in treating ASO.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Apolipoprotein A-I / blood
  • Apolipoprotein B-100
  • Apolipoproteins B / blood
  • Arteriosclerosis Obliterans / blood
  • Arteriosclerosis Obliterans / drug therapy*
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Apolipoprotein A-I
  • Apolipoprotein B-100
  • Apolipoproteins B
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Drugs, Chinese Herbal